En los estudios AMIGO, exenatida sc 2 veces al da a dosis de 5 y 10g, mostr una prdida ponderal promedio de 1,60 a 2,70kg, lo que represent entre 1,80 y 3,10% del peso corporal inicial14
Additionally, insufficient documentation regarding peptide purity or analytical validation may introduce uncertainty in experimental interpretation
Results are often noticeable shortly after the treatment, with benefits lasting several days to a week, depending on the individual and the type of IV infusion
2015;2015:817849. Talasaz, Azita Hajhossein & Khalili, Hossein & Fahimi, Fanak & Mojtaba, Salarifar
Nervous system disorders Uncommon: Headache Not known: Convulsions*, Dizziness Heart disease Not known: Palpitations Vascular pathologies Uncommon: Hypertension, Hypotension Respiratory, thoracic and mediastinal pathologies Not known: Dyspnea Gastrointestinal disorders Common: Vomiting, Nausea, Diarrhea, Abdominal pain Uncommon: Dysgeusia, Dyspepsia, Dry mouth Skin and subcutaneous tissue disorders Uncommon: Abnormal skin odor ** Not known: Itching, Skin rash Musculoskeletal and connective tissue disorders Uncommon: Muscle spasms Not known: Myasthenia***, Muscle tension Systemic disorders and conditions related to the administration site Uncommon: Chest pain, Feeling abnormal, Pyrexia, Injection site reaction**** Diagnostic tests Uncommon: Increased blood pressure Very rare: Increased INR*****
